Abstract:
OBJECTIVE:The heterogeneous spectrum of systemic lupus erythematosus (SLE) often presents with secondary complications such as cardiovascular disease (CVD), infections and neoplasms. Our study assessed whether the presence of SLE independently increases or reduces the disparities, accounting for the already higher risk of these outcomes among racial/ethnic minority groups without SLE. METHODS:We defined a cohort using electronic health records data (2005-2016) from a mixed-payer community-based outpatient setting in California serving patients of diverse racial/ethnic backgrounds. The eligible population included adult patients with SLE and matched non-SLE patients (≥18 years old). SLE was the primary exposure. The following outcomes were identified: pneumonia, other infections, CVD and neoplasms. For each racial/ethnic group, we calculated the proportion of incident co-morbidities by SLE exposure, followed by logistic regression for each outcome with SLE as the exposure. We evaluated interaction on the additive and multiplicative scales by calculating the relative excess risk due to interaction and estimating the cross-product term in each model. RESULTS:We identified 1036 SLE cases and 8875 controls. The incidence for all outcomes was higher among the SLE exposed. We found little difference in the odds of the outcomes associated with SLE across racial/ethnic groups, even after multivariable adjustment. This finding was consistent on the multiplicative and additive scales. CONCLUSION:We demonstrated that SLE status does not independently confer substantial interaction or heterogeneity by race/ethnicity toward the risk of pneumonia, other infections, CVD or neoplasms. Further studies in larger datasets are necessary to validate this novel finding.
journal_name
Lupusjournal_title
Lupusauthors
Falasinnu T,Chaichian Y,Li J,Chung S,Waitzfelder BE,Fortmann SP,Palaniappan L,Simard JFdoi
10.1177/0961203319884646subject
Has Abstractpub_date
2019-12-01 00:00:00pages
1619-1627issue
14eissn
0961-2033issn
1477-0962journal_volume
28pub_type
杂志文章相关文献
LUPUS文献大全abstract:BACKGROUND:The aim of this study was to explore the association between tumor necrosis factor superfamily number 4 (TNFSF4) rs1234315, rs2205960 polymorphisms and systemic lupus erythematosus (SLE) susceptibility. METHODS:A meta-analysis was performed on the association between rs1234315 and rs2205960 polymorphisms an...
journal_title:Lupus
pub_type: 杂志文章,meta分析
doi:10.1177/0961203319862610
更新日期:2019-09-01 00:00:00
abstract::Coming from Hans Wigzell's laboratory in Uppsala, Sweden, I joined the Kunkel laboratory in 1981 to spend a post-doctoral fellowship period financed by the German Research Organization. While I initially worked with Nick Chiorazzi in an attempt to generate monoclonal antibody-secreting human B-cell hybridomas, I later...
journal_title:Lupus
pub_type: 传,历史文章,杂志文章
doi:10.1191/0961203303lu355xx
更新日期:2003-01-01 00:00:00
abstract::The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (ACR) Damage Index (SDI) is an accepted instrument to ascertain damage. It has been shown to vary among different SLE populations. The aim of this study was to assess SDI score, pattern and factors related to damage in Brazilian SL...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203303lu447xx
更新日期:2003-01-01 00:00:00
abstract::Systemic lupus erythematosus is the prototypic multi-system autoimmune disease characterized by the production of multiple autoantibodies. The development of disease depends on a genetic predisposition and exposure to environmental factors including UV light, drugs, and infections. The association of parasitic infecti...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203309345735
更新日期:2009-11-01 00:00:00
abstract::A 24 year old female with hereditary spastic paraplegia presented with intermittent headache for one year. She also had lower abdominal pain and vomiting for two months. She was pale, had icterus and mild splenomegaly. On diagnostic evaluation she was found to have hemolytic anemia, thrombocytopenia and bilateral adre...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203315573853
更新日期:2015-09-01 00:00:00
abstract:BACKGROUND:This study aimed to investigate whether early eradication therapy influences systemic lupus erythematosus (SLE) risk in patients with Helicobacter pylori (HP) infection. METHODS:We identified 41,653 patients with HP infection in Taiwan from 2000 to 2013. The patient population was divided into early (within...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320923393
更新日期:2020-06-01 00:00:00
abstract:BACKGROUND:Complement activation plays a role in pathogenesis of the antiphospholipid syndrome (APS), but the involvement of the C5b-9 membrane attack complex (MAC) is unknown. Here we studied the effects of human polyclonal antiphospholipid (aPL) antibodies on thrombosis and tissue factor (TF) up-regulation in C6 defi...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203312458839
更新日期:2012-12-01 00:00:00
abstract:INTRODUCTION:Identifying factors predicting adverse pregnancy outcomes involving systemic lupus erythematosus (SLE) is a research priority. The aims of this study were to investigate (a) the maternal and fetal outcomes of pregnant lupus patients and the factors associated with adverse pregnancy outcomes, and (b) the ef...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320944503
更新日期:2020-10-01 00:00:00
abstract::The mouse model described in this study offers a unique method of determining the characteristics and mechanism(s) of action of aCL antibodies in thrombosis in vivo. In addition, this animal model enables the study of the kinetics of formation and dissolution of thrombus, as well as clot area, to be studied in a dynam...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/096120339400300408
更新日期:1994-08-01 00:00:00
abstract::Variations at the ITGAM gene, which encodes for the CD11b chain of the Mac-1 (alphaMbeta2; CD11b/CD18; complement receptor-3) integrin, is one of the strongest genetic risk factors for systemic lupus erythematosus (SLE). More specifically, a genetic variant (rs1143679) which results in an arginine to histidine substit...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203313491851
更新日期:2013-06-01 00:00:00
abstract::The aim of this study was to determine the frequency of anti-prolactin autoantibodies and the relationship among anti-prolactin autoantibodies, serum prolactin (PRL) levels and lupus activity in paediatric patients with systemic lupus erythematosus (SLE) using a transversal study. One-hundred and three consecutive pae...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120330101001107
更新日期:2001-01-01 00:00:00
abstract:OBJECTIVE:We aimed to develop a model of the illness experience for youth with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD). METHODS:We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, age 11 to 22 years, and their parents. We qualitatively defined key featur...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316646460
更新日期:2016-08-01 00:00:00
abstract::Anti-idiotypic antibody and its F(ab')2 fragments prepared from pooled normal human IgG had a partial inhibitory effect on the spontaneous in vitro secretion of anti-DNA antibodies from blood mononuclear cells of lupus patients. The inhibitory effect was specific for anti-DNA secretion as the anti-idiotype failed to i...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339300200607
更新日期:1993-12-01 00:00:00
abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...
journal_title:Lupus
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1191/0961203304lu1067sr
更新日期:2004-01-01 00:00:00
abstract::Progressive multifocal leukoencephalopathy (PML) is a rare, deadly demyelinating disease of the central nervous system, which is caused by a reactivation of the DNA polyomavirus JC and occurs in immunosuppressed individuals. So far, only 25 cases have been described in patients with SLE and none survived without antiv...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308089445
更新日期:2008-11-01 00:00:00
abstract::Lymphocytic vasculitis (LV) characterises systemic lupus erythematosus (SLE) and this potentially reversible lesion, which may be subclinical, may imply overt systemic disease activity. Needle quadriceps muscle biopsy was performed in 26 unselected patients with SLE and the presence of LV in these muscle specimens was...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339500400213
更新日期:1995-04-01 00:00:00
abstract:BACKGROUND AND OBJECTIVES:Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to pe...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203311434939
更新日期:2012-04-01 00:00:00
abstract:OBJECTIVES:To estimate the prevalence of pulmonary arterial hypertension (PAH) and risk factors for PAH in patients registered in the Chinese SLE Treatment and Research group (CSTAR) database, the first online registry of Chinese patients with systemic lupus erythematosus (SLE). METHODS:A prospective cross-sectional s...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203314527366
更新日期:2014-09-01 00:00:00
abstract::The aim of this study is to determine prevalence, clinical significance of antiphospholipid antibodies (aPL) including anticardiolipin antibodies (aCL), anti-beta2GP1 and lupus anticoagulant (LA) in a cohort of 74 patients with primary Sjögren's syndrome (pSS) according to revised European criteria. aPL were found in ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203304lu1006oa
更新日期:2004-01-01 00:00:00
abstract:INTRODUCTION:The objective of this study is to determine whether serum concentrations of B cell activating factor from the tumour necrosis factor family (BAFF) and/or a proliferation-inducing ligand (APRIL) are associated with clinical manifestations of systemic lupus erythematosus (SLE). METHODS:BAFF and APRIL concen...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203313496302
更新日期:2013-08-01 00:00:00
abstract::The outcome, quality of life and prognosis of lupus patients can be enhanced with close follow up and coordination between the individual's primary care physician and rheumatologist. Rheumatologists usually do not act as primary care physicians and leave health care maintenance to practitioners who need to be reminded...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203307086267
更新日期:2008-02-01 00:00:00
abstract::Recent studies have suggested an association between primary antiphospholipid syndrome (PAPS), antiphospholipid antibodies and some major histocompatibility complex (MHC) antigens. We have studied the relationship between MHC class II antigens and PAPS in 19 patients from the south of Spain. Univariant analysis showed...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339500400111
更新日期:1995-02-01 00:00:00
abstract:OBJECTIVE:This study aimed to explore the risk factors for 'severe' neuropsychiatric (NP) flare in patients with systemic lupus erythematosus (SLE). METHODS:This retrospective study comprised newly diagnosed 184 adult SLE patients who visited Hokkaido University Hospital between 2006 and 2017. In this study, severe NP...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320938453
更新日期:2020-09-01 00:00:00
abstract::Neuropsychiatric lupus is a well-recognized complication of systemic lupus erythematosus (SLE) and encompasses a wide variety of neurological manifestations. Although isolated cranial nerve involvement is rare, it can cause significant morbidity and disability. This report describes a case with isolated vagus nerve in...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203307080632
更新日期:2007-01-01 00:00:00
abstract::Systemic Lupus Erythematosus is an autoimmune disease with symptoms pervasive to all organ systems. It affects more females as compared to males (in the ratio 9:1). Oxidative stress plays a major role in the pathogenesis of SLE and other autoimmune diseases. In order to understand the relationship between cell specifi...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320959441
更新日期:2020-12-01 00:00:00
abstract::Objective Several studies have evaluated the prevalence of rheumatoid factor (RF) and anti-citrullinated proteins antibodies (ACPA) in systemic lupus erythematosus (SLE) patients but no data are available on the anti-carbamylated proteins (anti-CarP), a new biomarker for rheumatoid arthritis (RA). We evaluated the ant...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203317713141
更新日期:2018-01-01 00:00:00
abstract::One hundred and fifty-eight patients with SLE were prospectively studied at a tertiary referral centre in India to ascertain the prevalence and clinical profile of fibromyalgia (FM) in Indian patients with lupus. An attempt was made to determine whether socio-demographic factors or disease characteristics differ in SL...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/096120398678920497
更新日期:1998-01-01 00:00:00
abstract::Platelet activation and decrease in platelet count characterize the development of the most feared form of antiphospholipid syndrome (APS), i.e. catastrophic APS (CAPS). We aimed to assess if immuno-affinity purified anti-β2-glycoprotein I (aβ2GPI) antibodies enhance platelet activation inducing a significant flow obs...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203319886915
更新日期:2019-12-01 00:00:00
abstract::We studied the effect of beta 2-GPI on binding of antibodies in sera from patients with leprosy and patients with the antiphospholipid syndrome (APS) to CL in enzyme-linked immunosorbent assays (ELISAs). Increased levels of IgG aCL were detected in 59 of 61 leprosy patients' sera by the standard aCL-ELISA in the prese...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339400300615
更新日期:1994-12-01 00:00:00
abstract::Numerous drugs have been linked to the induction or exacerbation of systemic cutaneous lupus erythematosus (SCLE). This report presents the third case of the biologic abatacept as an exacerbating medication for SCLE. A 73-year old woman with a remote history of subacute cutaneous lupus and rheumatoid arthritis, well c...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320981146
更新日期:2020-12-22 00:00:00